Zydus Lifesciences Limited (ZYDUSLIFE)
Outcome of AGM
Outcome of 31st Annual General Meeting held on August 11, 2026
- All 9 resolutions including audited financial statements and final dividend declared
- Final dividend of Re. 1.00 per equity share for FY ended March 31, 2026 approved
- Re-appointment of Mr. Pankaj R. Patel and Mr. Mukesh M. Patel as directors by rotation
- Re-appointment of Dr. Sharvil P. Patel as Managing Director for 5 years from April 1, 2027
- Appointment of Mr. Kulin S. Lalbhai as Independent Director for 5 years
- Commission payment to non-executive directors approved up to ₹40 million per year
- Voting conducted via remote e-voting and e-voting during AGM; all resolutions passed with requisite majority
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ZYDUSLIFE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ZYDUSLIFE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Zydus Lifesciences Limited
Important.
The summary above is generated automatically from Zydus Lifesciences Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.